S. 586 117th Congress Senate

NOPAIN Act

Official title: A bill to amend title XVIII of the Social Security Act to combat the opioid crisis by promoting access to non-opioid treatments in the hospital outpatient setting.

Introduced: December 7, 2021 Introduced by: Shelley Moore Capito Republican · West Virginia See on congress.gov

Health Congressional oversightDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco use

More subjectsShow fewer subjects

Health care coverage and accessHealth care qualityHealth technology, devices, suppliesHome and outpatient careHospital careMedicarePrescription drugsSurgery and anesthesia

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Mar 4, 2021

Read twice and referred to the Committee on Finance.

Mar 4, 2021

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action March 4, 2021

Read twice and referred to the Committee on Finance.

Plain-English summary Congressional Research Service

Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act

This bill temporarily establishes separate payments for certain non-opioid treatments under the Medicare prospective payment system for hospital outpatient department services and the payment system for ambulatory surgical center services. The bill applies to pain management treatments that are able to replace or reduce opioid consumption, as shown through clinical trials or data.

Related & companion bills 3

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Finance Committee
Senate

Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

AMERICAN SOCIETY OF ANESTHESIOLOGISTS
for AMERICAN SOCIETY OF ANESTHESIOLOGISTS · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
AMERICAN SOCIETY OF ANESTHESIOLOGISTS
for AMERICAN SOCIETY OF ANESTHESIOLOGISTS · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
AMERICAN SOCIETY OF ANESTHESIOLOGISTS
for AMERICAN SOCIETY OF ANESTHESIOLOGISTS · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
AMERICAN SOCIETY OF ANESTHESIOLOGISTS
for AMERICAN SOCIETY OF ANESTHESIOLOGISTS · District of Columbia · 2nd Quarter 2025 (Apr 1 - June 30)
AMERICAN SOCIETY OF ANESTHESIOLOGISTS
for AMERICAN SOCIETY OF ANESTHESIOLOGISTS · District of Columbia · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

Agency for Healthcare Research & Quality (AHRQ)
5 filings
Centers For Disease Control & Prevention (CDC)
5 filings
Centers For Medicare and Medicaid Services (CMS)
5 filings
Defense, Dept of (DOD)
5 filings
Drug Enforcement Administration (DEA)
5 filings
Executive Office of the President (EOP)
5 filings
Federal Trade Commission (FTC)
5 filings
Food & Drug Administration (FDA)
5 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

Cosponsors 44